Light Chain Bioscience | Novimmune SA

Switzerland · 82 Employees
NovImmune has successfully divested EmaCo AG, a newly established company owning emapalumab and related assets to Sobi on 18 July 2019. NovImmune SA will continue to operate and focus on its bispecific technology and associated programs and will rebrand as: "Light Chain Bioscience – A brand of Novimmune SA". The brand Light Chain Bioscience brings to life the research and development of novel multi-specific antibodies that rely on their light chain for their function. A key distinctive feature of these multispecific antibodies is their native human structure, making them well tolerated and easy to develop. Thus far, NovImmune has advanced seven drug candidates to treat a range of conditions. The Company's pipeline is a balance of preclinical and clinical candidates for validated and novel targets. NovImmune has established a next-generation antibody drug discovery platform that includes novel bispecific antibody drug capabilities - the simple, stable and smart kappa-lambda-body™. In 2009, NovImmune received the European Biotechnica Award. In 2010, NovImmune entered a partnership with Genentech to advance the Company's anti-IL17 drug candidate. In addition to pursuing additional drug discovery, development and commercialization partnerships, the Company plans to bring selected drugs to market for focused applications.

概述

国家 Switzerland
成立时间 1998
总部 3 chemin du pré-fleuri, plan-les-ouates, geneva, switzerland
电话号码 +41 22 552 72 00
网站 http://www.lightchainbio.com
LinkedIn http://www.linkedin.com/company/novimmune
Twitter
Facebook
员工数 82
行业 research,
简介 The brand Light Chain Bioscience brings to life the research and development of novel multi-specific antibodies that rely on their light chain for their function.

技术

Bootstrap Framework

CSS and JavaScript Libraries

Google Analytics

Analytics and Tracking

Microsoft Office 365

Other

Mobile Friendly

Other

Nginx

Load Balancers

常见问题

Light Chain Bioscience | Novimmune SA 在哪里?

Light Chain Bioscience | Novimmune SA 的总部位于 3 chemin du pré-fleuri, plan-les-ouates, geneva, switzerland

Light Chain Bioscience | Novimmune SA 的电话号码是多少?

Light Chain Bioscience | Novimmune SA 的电话号码是 +41 22 552 72 00

Light Chain Bioscience | Novimmune SA 的官方网站是什么?

Light Chain Bioscience | Novimmune SA 的公司官方网站是 http://www.lightchainbio.com

Light Chain Bioscience | Novimmune SA 是做什么的?

The brand Light Chain Bioscience brings to life the research and development of novel multi-specific antibodies that rely on their light chain for their function.

Light Chain Bioscience | Novimmune SA 的业务有哪些?

nextgeneration antibody drug discovery,immunology,bispecific antibody drugs,clinical development

Light Chain Bioscience | Novimmune SA 的年收入是多少?

Light Chain Bioscience | Novimmune SA 的收入是 32000000美元

Light Chain Bioscience | Novimmune SA 有多少员工?

Light Chain Bioscience | Novimmune SA 有 82 名员工

Light Chain Bioscience | Novimmune SA 属于哪个行业?

Light Chain Bioscience | Novimmune SA 从事以下行业: research

Light Chain Bioscience | Novimmune SA 使用什么技术?

Light Chain Bioscience | Novimmune SA 使用的一些流行技术包括: Bootstrap Framework,Google Analytics,Microsoft Office 365,Mobile Friendly,Nginx

如何联系 Light Chain Bioscience | Novimmune SA?

Light Chain Bioscience | Novimmune SA 联系信息: 电话号码:+41 22 552 72 00, 网站:http://www.lightchainbio.com, 邮箱:eri***@***.com

Light Chain Bioscience | Novimmune SA 的社交媒体链接是什么?

Light Chain Bioscience | Novimmune SA 领英:http://www.linkedin.com/company/novimmune,fackbook:,twitte:

Light Chain Bioscience | Novimmune SA 是一家上市公司吗?

不是

Light Chain Bioscience | Novimmune SA 的最后一轮融资是什么时候?

Light Chain Bioscience | Novimmune SA在2016-05-01T00:00:00.000+00:00结束了最后一轮融资,金额达31M$。

谁投资 Light Chain Bioscience | Novimmune SA?

Light Chain Bioscience | Novimmune SA 有 3 家投资者,包括 、Rosetta Capital Limited, BZ Bank, Pictet, Lombard Odier Darier Hentsch, Novartis Venture Funds, Aravis Venture、Rosetta Capital Limited。

管理层

Eric Hatterer

Discovery Program Leader - Senior Scientist

Yves Poitevin

Head of Bioprocessing unit

Anne Papaioannou

Senior Research Associate in Non-Clinical Safety

Krzysztof Masternak

Director, Drug Discovery

员工

Fabien Cusin

Senior Research Assistant

Corinne Gbame

Research assistant

Nicolas Bosson

Research Associate

Xavier Chauchet

Discovery Program Leader, Scientist

外贸获客 查找关键决策人

10亿+海关交易数据,1.2亿企业数据,2亿+企业联系人数据,1000千万真实采购商。覆盖200+个国家及地区,95%外贸重点拓展市场,可根据行业、经营范围等多方位挖掘目标客户。
免费试用

Top-ranked on G2 Crowd

全球B2B企业库 海关贸易数据 展会采购数据

工作更少,成就更大,销售更聪明

查找更多 B2B 联系人,丰富并验证记录
Email Address

全球B2B企业库

海关贸易数据

展会采购数据

Top-ranked on G2 Crowd

OR
Sign Up with Google